These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

250 related articles for article (PubMed ID: 26684170)

  • 1. The Haptoglobin genotype predicts cardio-renal mortality in type 1 diabetes.
    Costacou T; Orchard TJ
    J Diabetes Complications; 2016 Mar; 30(2):221-6. PubMed ID: 26684170
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Haptoglobin genotype and cerebrovascular disease incidence in type 1 diabetes.
    Costacou T; Secrest AM; Ferrell RE; Orchard TJ
    Diab Vasc Dis Res; 2014 Sep; 11(5):335-42. PubMed ID: 24994788
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Hypothesis--haptoglobin genotype and diabetic nephropathy.
    Nakhoul FM; Miller-Lotan R; Awaad H; Asleh R; Levy AP
    Nat Clin Pract Nephrol; 2007 Jun; 3(6):339-44. PubMed ID: 17525716
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The protean role of haptoglobin and haptoglobin genotypes on vascular complications in diabetes mellitus.
    Dalan R; Liuh Ling G
    Eur J Prev Cardiol; 2018 Sep; 25(14):1502-1519. PubMed ID: 29799294
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Haptoglobin genotype and renal function decline in type 1 diabetes.
    Costacou T; Ferrell RE; Ellis D; Orchard TJ
    Diabetes; 2009 Dec; 58(12):2904-9. PubMed ID: 19720796
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The PPAR gamma 2 Pro12Ala variant predicts ESRD and mortality in patients with type 1 diabetes and diabetic nephropathy.
    Jorsal A; Tarnow L; Lajer M; Ek J; Hansen T; Pedersen O; Parving HH
    Mol Genet Metab; 2008 Jul; 94(3):347-51. PubMed ID: 18467141
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Soluble Urokinase Plasminogen Activator Receptor Predicts Cardiovascular Events, Kidney Function Decline, and Mortality in Patients With Type 1 Diabetes.
    Rotbain Curovic V; Theilade S; Winther SA; Tofte N; Eugen-Olsen J; Persson F; Hansen TW; Jeppesen J; Rossing P
    Diabetes Care; 2019 Jun; 42(6):1112-1119. PubMed ID: 30885954
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Arterial Stiffness Predicts Mortality in Individuals With Type 1 Diabetes.
    Tynjälä A; Forsblom C; Harjutsalo V; Groop PH; Gordin D;
    Diabetes Care; 2020 Sep; 43(9):2266-2271. PubMed ID: 32647049
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Arterial stiffness and endothelial dysfunction independently and synergistically predict cardiovascular and renal outcome in patients with type 1 diabetes.
    Theilade S; Lajer M; Jorsal A; Tarnow L; Parving HH; Rossing P
    Diabet Med; 2012 Aug; 29(8):990-4. PubMed ID: 22414297
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Haptoglobin genotype and risk of diabetic nephropathy in patients with type 1 diabetes mellitus: a study on a Spanish population.
    Amor AJ; Canivell S; Oriola J; Ricart MJ; de Hollanda AM; Bosch-Comas A; Esmatjes E
    Nefrologia; 2014; 34(2):212-5. PubMed ID: 24658196
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The haptoglobin 2-2 genotype is associated with cardiac autonomic neuropathy in type 1 diabetes: the RETRO HDLc study.
    Ju J; Tomaszewski EL; Orchard TJ; Evans RW; Feingold E; Costacou T
    Acta Diabetol; 2020 Mar; 57(3):271-278. PubMed ID: 31529337
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Increased renal hypertrophy in diabetic mice genetically modified at the haptoglobin locus.
    Miller-Lotan R; Herskowitz Y; Kalet-Litman S; Nakhoul F; Aronson D; Zoabi R; Asaf R; Ben-Izhak O; Sabo E; Lim SK; Baumann H; Berger FG; Levy AP
    Diabetes Metab Res Rev; 2005; 21(4):332-7. PubMed ID: 15852445
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Mortality following a cardiovascular or renal event in patients with type 2 diabetes in the ALTITUDE trial.
    Jhund PS; McMurray JJ; Chaturvedi N; Brunel P; Desai AS; Finn PV; Haffner SM; Solomon SD; Weinrauch LA; Claggett BL; Pfeffer MA
    Eur Heart J; 2015 Sep; 36(36):2463-9. PubMed ID: 26188211
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Plasma Copeptin, Kidney Outcomes, Ischemic Heart Disease, and All-Cause Mortality in People With Long-standing Type 1 Diabetes.
    Velho G; El Boustany R; Lefèvre G; Mohammedi K; Fumeron F; Potier L; Bankir L; Bouby N; Hadjadj S; Marre M; Roussel R
    Diabetes Care; 2016 Dec; 39(12):2288-2295. PubMed ID: 27729425
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Association between haptoglobin gene variants and diabetic nephropathy: haptoglobin polymorphism in nephropathy susceptibility.
    Conway BR; Savage DA; Brady HR; Maxwell AP
    Nephron Exp Nephrol; 2007; 105(3):e75-9. PubMed ID: 17220636
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Does the Concentration of Oxidative and Inflammatory Biomarkers Differ by Haptoglobin Genotype in Type 1 Diabetes?
    Costacou T; Evans RW; Orchard TJ
    Antioxid Redox Signal; 2015 Dec; 23(18):1439-44. PubMed ID: 26114833
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Haptoglobin phenotype and vascular complications in patients with diabetes.
    Levy AP; Roguin A; Hochberg I; Herer P; Marsh S; Nakhoul FM; Skorecki K
    N Engl J Med; 2000 Sep; 343(13):969-70. PubMed ID: 11012324
    [No Abstract]   [Full Text] [Related]  

  • 18. A polymorphism in the gene encoding carnosinase (CNDP1) as a predictor of mortality and progression from nephropathy to end-stage renal disease in type 1 diabetes mellitus.
    Alkhalaf A; Bakker SJ; Bilo HJ; Gans RO; Navis GJ; Postmus D; Forsblom C; Groop PH; Vionnet N; Hadjadj S; Marre M; Parving HH; Rossing P; Tarnow L
    Diabetologia; 2010 Dec; 53(12):2562-8. PubMed ID: 20711718
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Pharmacogenomic effect of vitamin E on kidney structure and function in transgenic mice with the haptoglobin 2-2 genotype and diabetes mellitus.
    Nakhoul FM; Miller-Lotan R; Awad H; Asleh R; Jad K; Nakhoul N; Asaf R; Abu-Saleh N; Levy AP
    Am J Physiol Renal Physiol; 2009 Apr; 296(4):F830-8. PubMed ID: 19176700
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Effect of vitamin E supplementation on HDL function by haptoglobin genotype in type 1 diabetes: results from the HapE randomized crossover pilot trial.
    Costacou T; Levy AP; Miller RG; Snell-Bergeon J; Asleh R; Farbstein D; Fickley CE; Pambianco G; de la Vega R; Evans RW; Orchard TJ
    Acta Diabetol; 2016 Apr; 53(2):243-50. PubMed ID: 26002590
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.